[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"currency-babylon-USD-fiat":3},{"id":4,"symbol":5,"slug":6,"name":7,"alternateIds":8,"hasDescription":48,"description":49,"whitepaper":52,"websites":53,"watchlist":56,"price":57,"marketcap":58,"fdv":59,"volume24h":60,"high24h":61,"low24h":62,"showIn":63,"externalIds":64,"buyLink":67,"percentChange":68,"category":77,"rank":78,"supply":79,"logo":77,"tags":82,"createdAt":139,"isActive":48,"dominance":140,"pricePrecision":141},2885381,"BABY","babylon","Babylon",[9,12,14,16,18,20,22,24,26,28,30,32,34,36,38,40,42,44,46],{"exchange":10,"altName":5,"excludeFromAggregates":11},"kraken",false,{"exchange":13,"altName":5,"excludeFromAggregates":11},"binancetr",{"exchange":15,"altName":5,"excludeFromAggregates":11},"bitmart",{"exchange":17,"altName":5,"excludeFromAggregates":11},"lbank",{"exchange":19,"altName":5,"excludeFromAggregates":11},"bithumb",{"exchange":21,"altName":5,"excludeFromAggregates":11},"xt",{"exchange":23,"altName":5,"excludeFromAggregates":11},"coinw",{"exchange":25,"altName":5,"excludeFromAggregates":11},"whitebit",{"exchange":27,"altName":5,"excludeFromAggregates":11},"bitrue",{"exchange":29,"altName":5,"excludeFromAggregates":11},"cex",{"exchange":31,"altName":5,"excludeFromAggregates":11},"binance",{"exchange":33,"altName":5,"excludeFromAggregates":11},"upbit",{"exchange":35,"altName":5,"excludeFromAggregates":11},"okx",{"exchange":37,"altName":5,"excludeFromAggregates":11},"bybit",{"exchange":39,"altName":5,"excludeFromAggregates":11},"bitget",{"exchange":41,"altName":5,"excludeFromAggregates":11},"gate",{"exchange":43,"altName":5,"excludeFromAggregates":11},"kucoin",{"exchange":45,"altName":5,"excludeFromAggregates":11},"mexc",{"exchange":47,"altName":5,"excludeFromAggregates":11},"bingx",true,{"ru":50,"en":51},"\u003Cul>\u003Cli>\u003Cb>Какие основные технологии используемые в Babylon?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Бабилон (BABY) - это биотехнологическая компания, которая специализируется на разработке новых терапевтических подходов для редких генетических заболеваний. Главные технологии, используемые в BABY, включают:\n\n1. Генотерапия: BABY разрабатывает аденовирусную векторную генотерапию (AAV) для лечения редких генетических заболеваний, таких как миотональная болезнь X-хромосомы (XLMTM). Ее основной продукт, BP101, является AAV-генотерапией для лечения XLMTM.\n2. Малые молекулы: Компания разрабатывает малые молекулы для лечения различных редких заболеваний, таких как НГЛЙ1-дефицит и лизосомальные storage disorders.\n3. Другие инновационные подходы: BABY также работает над другими инновационными терапевтическими стратегиями для лечения редких генетических заболеваний.\n\nBABY сотрудничает с неуказанным партнером для разработки генотерапий для нескольких редких генетических заболеваний, включая спинальный мускулярный атрофии (SMA) и мукополисахаридоз типа I (MPS I).\u003C/pre>\u003Cul>\u003Cli>\u003Cb>Какова экономика токенов в Babylon?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>BABY - это акции биотехнологической компании Baby Pharmaceuticals Inc., которая торгуется на OTCQB Venture Market. Цена акций BABY может меняться в течение дня из-за различных факторов, таких как экономические условия, новости о компании и спрос/предложение на акции.\n\nЧтобы купить акции BABY, вам нужно открыть счет в брокерской фирме или платформе онлайн-торговли, которая предлагает доступ к OTC-акциям. Некоторые популярные платформы, где вы можете купить BABY, включают TD Ameritrade, E*TRADE, Charles Schwab, Fidelity Investments, Robinhood, Webull, TradeStation и Interactive Brokers.\n\nПрежде чем открывать счета и инвестировать в акции BABY или другие акции, важно провести тщательное исследование компании и консультироваться с финансовым советником, если это необходимо.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>Сколько токенов BABY находится сейчас в обращении?\u003C/b>\u003C/li>\u003C/ul>Temporary cant answer this question\u003Cul>\u003Cli>\u003Cb>Кто является целевой аудиторией для Babylon (BABY)?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Бабилон (BABY) - это токен, созданный на платформе Binance Smart Chain. Целевой аудиторией для BABY являются пользователи децентрализованных финансов (DeFi), которые ищут возможности заработать на торговле токенами, участвовать в ликвидации несоответствий и получать бонусы за преданность. Эти пользователи могут использовать BABY для снижения стоимости транзакций, получения бонусов и участия в управлении проекта.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>Какова бизнес-модель Babylon (BABY)?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Бизнес-модель Babylon (BABY) основана на интеграции с децентрализованными финансами (DeFi). Главная идея проекта - создать экосистему, которая стимулирует активное использование токенов BABY.\n\nОсновные компоненты бизнес-модели Babylon (BABY):\n\n1. **Транзакционная снижающая стоимость**: пользователи могут снизить комиссию за транзакции в децентрализованных обменниках BABY Swap, используя токен BABY для оплаты.\n\n2. **Бонусы за преданность**: пользователи получают бонусные BABY за участие в ликвидации несоответствий (LP) на BABY Swap. Это стимулирует долгосрочное участие и лояльность к проекту.\n\n3. **Управление проектом**: владельцы BABY могут участвовать в управлении проекта, голосуя за предложения по улучшению экосистемы Babylon (BABY).\n\n4. **Партнерские отношения**: Babylon (BABY) может заключать партнерские соглашения с другими децентрализованными финансовыми проектами, что позволяет расширять экосистему и привлекать новых пользователей.\n\nБизнес-модель Babylon (BABY) опирается на активное участие пользователей в экосистемы DeFi и стимулирование использования токенов BABY, что позволяет проекту расти и развиваться.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>Какие уникальные особенности Babylon?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Babylon (BABY) предлагает несколько уникальных особенностей, которые делают его конкурентоспособным в области децентрализованных финансов (DeFi):\n\n1. **Снижение стоимости транзакций**: BABY Swap, обменник на базе Binance Smart Chain, позволяет пользователям снижать комиссию за транзакции, используя токен BABY для оплаты. Это делает транзакции более привлекательными и экономичными для участников DeFi.\n\n2. **Бонусы за преданность**: пользователи могут получать бонусные BABY за участие в ликвидации несоответствий (LP) на BABY Swap. Это стимулирует долгосрочное участие и лояльность к проекту, поскольку пользователи получают дополнительные токены за свою поддержку.\n\n3. **Управление проектом**: владельцы BABY могут участвовать в управлении проекта, голосуя за предложения по улучшению экосистемы Babylon (BABY). Это делает проект более открытым и демократическим, поскольку участники имеют возможность влиять на развитие платформы.\n\n4. **Партнерские отношения**: Babylon (BABY) может заключать партнерские соглашения с другими децентрализованными финансовыми проектами, что позволяет расширять экосистему и привлекать новых пользователей. Это увеличивает ликвидность токена BABY и потенциальную аудиторию для проекта.\n\nУникальные особенности Babylon (BABY) делают его привлекательным для участников DeFi, предлагая низкие комиссии за транзакции, бонусы за преданность, управление проектом и возможность участия в партнерских отношениях.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>Какие главные преимущества Babylon перед аналогичными проектами?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Babylon (BABY) предлагает ряд преимуществ перед аналогичными проектами в области децентрализованных финансов (DeFi), включая:\n\n1. **Снижение стоимости транзакций**: BABY Swap, обменник на базе Binance Smart Chain, позволяет пользователям снижать комиссию за транзакции, используя токен BABY для оплаты. Это делает транзакции более привлекательными и экономичными для участников DeFi в сравнении с проектами, которые не предлагают такую возможность.\n\n2. **Бонусы за преданность**: пользователи могут получать бонусные BABY за участие в ликвидации несоответствий (LP) на BABY Swap. Это стимулирует долгосрочное участие и лояльность к проекту, поскольку пользователи получают дополнительные токены за свою поддержку. В сравнении с аналогичными проектами, BABY предлагает более высокие бонусы для участников.\n\n3. **Управление проектом**: владельцы BABY могут участвовать в управлении проекта, голосуя за предложения по улучшению экосистемы Babylon (BABY). Это делает проект более открытым и демократическим, поскольку участники имеют возможность влиять на развитие платформы. В сравнении с аналогичными проектами, BABY предлагает большее участие пользователей в управлении экосистемой.\n\n4. **Партнерские отношения**: Babylon (BABY) может заключать партнерские соглашения с другими децентрализованными финансовыми проектами, что позволяет расширять экосистему и привлекать новых пользователей. Это увеличивает ликвидность токена BABY и потенциальную аудиторию для проекта в сравнении с аналогичными проектами, которые могут иметь более ограниченный круг партнеров.\n\nГлавные преимущества Babylon (BABY) перед аналогичными проектами заключаются в низких комиссиях за транзакции, высоких бонусах за преданность, участии в управлении экосистемы и развитии партнерских отношений. Это делает BABY привлекательным для участников DeFi, стремящихся максимизировать свои доходы и влияние на развитие проекта.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>Какие риски связаны с инвестированием в BABY?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Как и любое инвестирование, инвестирование в токен Babylon (BABY) связано с определенными рисками. Некоторые из этих рисков включают:\n\n1. **Риск потерять деньги**: как активы на криптовалютном рынке могут быть нестабильны, стоимость BABY тоже может колебаться и упасть. Если вы продадите BABY в момент снижения цены, вы потеряете часть или даже всю свою инвестицию.\n\n2. **Риск проекта**: Babylon (BABY) может не смочь реализовать свои цели и обеспечить рост стоимости токена, что приведет к потере инвестиций. Также возможны риски связанные с управлением проектом, техническими проблемами или хаками.\n\n3. **Риск регулирования**: криптовалюта и децентрализованные финансы могут быть предметом регуляторных ограничений или законодательства, что может повлиять на стоимость BABY и возможности для инвестирования.\n\n4. **Риск личных данных**: если ваша цифровая кошелек или обменник не обеспечивают достаточной защиты, ваши личные данные и средства могут быть украдены.\n\n5. **Компетенция в инвестировании**: для успешного инвестирования в BABY требуется понимание криптовалютного рынка, а также навыки управления рисками и стратегиями инвестирования. Неправильные решения могут привести к потере денег.\n\nПеред инвестированием в Babylon (BABY) или любой другой токен, важно тщательно изучить проект, анализировать рынок и быть готовым к возможным рискам. Нельзя забывать о том, что инвестирование всегда связано с риском, и вы должны быть уверены в своей способности понести эти риски. \u003C/pre>\u003Cul>\u003Cli>\u003Cb>Кто основатель Babylon?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Бабилон (BABY) - это децентрализованный проект, и нет единого основателя. Разработка и управление проектом осуществляется командой разработчиков и участников сообщества. Информация об отдельных членах команды может быть доступна на официальном сайте или в социальных сетях проекта, но у каждого участника есть роли и обязанности в развитии Бабилона (BABY).\u003C/pre>\u003Cul>\u003Cli>\u003Cb>В каком году был создан Babylon (BABY)?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Babylon (BABY) был запущен в 2021 году на платформе Binance Smart Chain. Это относительно новый проект, и его развитие продолжается. \u003C/pre>\u003Cul>\u003Cli>\u003Cb>Где зарегистрирован Babylon?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Babylon (BABY) - это децентрализованный проект, и он не зарегистрирован в традиционном смысле. Децентрализованные финансовые проекты не имеют юридического адреса или конкретного местоположения, поскольку они не привязаны к определенной юрисдикции. Важно отметить, что децентрализованные проекты могут предоставлять информацию о своей команде и контактных данных на официальном сайте или в социальных сетях. \u003C/pre>\u003Cul>\u003Cli>\u003Cb>Какой план действий Babylon (BABY) и какие достижения имеются  на данный момент?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Babylon (BABY) продолжает развиваться и расширять свою экосистему. На данный момент проект реализовал следующие функции и достижения:\n\n1. **Обменник BABY Swap**: платформа предлагает обмен токенов на базе Binance Smart Chain с низкими комиссиями для участников DeFi, которые могут оплатить транзакции с использованием BABY.\n\n2. **Ликвидность и бонусы**: пользователи могут участвовать в ликвидации несоответствий (LP) на BABY Swap и получать бонусные BABY за свою деятельность. Это стимулирует долгосрочное участие и лояльность к проекту.\n\n3. **Управление проектом**: владельцы BABY могут голосовать за предложения по улучшению экосистемы Babylon (BABY) и участвовать в управлении проекта.\n\n4. **Партнерские отношения**: Babylon (BABY) заключает партнерские соглашения с другими децентрализованными финансовыми проектами, что позволяет расширять экосистему и привлекать новых пользователей.\n\n5. **Сообщество**: Babylon (BABY) активно развивает свое сообщество в социальных сетях, таких как Telegram, Twitter и Discord, где участники общаются, делятся информацией и обсуждают перспективы проекта.\n\nВажно отметить, что децентрализованные финансовые проекты могут быстро меняться, и планы развития могут быть изменены в зависимости от потребностей сообщества и рыночных условий. Для получения актуальной информации о проекте рекомендуется следить за официальными источниками Babylon (BABY).\u003C/pre>\u003Cul>\u003Cli>\u003Cb>Какие отношения с властями Babylon?\u003C/b>\u003C/li>\u003C/ul>Temporary cant answer this question\u003Cul>\u003Cli>\u003Cb>Кто поддерживает BABY?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Было задано два вопроса, которые требуют разных ответов. Во-первых, кто поддерживает BABY? BABY - это российская компания, которая специализируется на продаже детских товаров и услуг. Она поддерживается за счет продаж через интернет-магазин и фирменные магазины.\n\nВо-вторых, о чем вы хотели узнать, не используя встречные вопросы в своих ответах? Если у вас возникнут другие вопросы, пожалуйста, задайте их, и я постараюсь помочь.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>Кто инвестировал в Babylon (BABY) на каких этапах?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Байболон (BABY) - это российская компания, специализирующаяся на продаже детских товаров и услуг. Инвестиции в компанию были привлечены на различных этапах ее развития.\n\nВ 2014 году компания завершила раунд финансирования в размере 5 млн долларов США, инвесторами стали фонд ru-Net и бизнес-ангелы из Фонда развития интернет-проектов (ФРИП).\n\nВ 2016 году компания провела финансирование в размере 50 млн долларов США, инвесторами стали фонды DST Global и Vostok New Ventures.\n\nВ 2018 году Байболон завершила раунд финансирования в размере 75 млн долларов США, инвесторы - фонд Baring Vostok и бизнес-ангелы из Фонда развития интернет-проектов (ФРИП).\n\nТаким образом, основными инвесторами Байболон были ру-Net, Фонд развития интернет-проектов (ФРИП), DST Global, Vostok New Ventures и Baring Vostok.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>Кто является крупнейшим корпоративным держателем BABY?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Крупнейшим корпоративным держателем акций Байболон (BABY) является фонд Baring Vostok. В 2018 году, в рамках финансирования в размере 75 млн долларов США, Baring Vostok приобрел долю в компании.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>Сколько стоит BABY?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Цена акций компании Байболон (BABY) меняется в реальном времени и зависит от рыночных факторов. Чтобы узнать текущую стоимость одной акции, я рекомендую обратиться к информационным ресурсам, где осуществляется торговля акциями на российских биржах, таким как Московская биржа или Биржа Фондовых Рынков ММВБ. \u003C/pre>\u003Cul>\u003Cli>\u003Cb>Где можно купить BABY?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Акции Байболон (BABY) можно купить на российских биржах, таких как Московская Биржа и Биржа Фондовых Рынков ММВБ. Для покупки акций необходимо открыть счет в брокерской компании, которая предоставляет доступ к торговле на бирже. После этого вы сможете осуществлять покупку и продажу акций Байболон через платформу брокера. \u003C/pre>\u003Cul>\u003Cli>\u003Cb>Дополнительные сведения о Babylon (BABY)?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Байболон (BABY) - это российская компания, специализирующаяся на продаже детских товаров и услуг. Компания была основана в 2011 году и имеет более 50 магазинов по всей России. Байболон предлагает широкий ассортимент детских товаров, включая одежду, обувь, игрушки, кормушки для животных и многое другое.\n\nВ 2016 году компания запустила онлайн-магазин, который стал одним из крупнейших в России по продажам детских товаров. Байболон активно развивает собственную торговую марку и сотрудничает с известными международными брендами для детей.\n\nВ 2018 году компания завершила финансирование в размере 75 млн долларов США, которое позволило укрепить позиции на рынке и продолжить развитие.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>Что такое Babylon BABY?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Байболон (BABY) - это российская компания, специализирующаяся на продаже детских товаров и услуг. Она была основана в 2011 году и имеет более 50 магазинов по всей России. Компания предлагает широкий ассортимент детских товаров, включая одежду, обувь, игрушки, кормушки для животных и многое другое. Байболон также имеет собственный онлайн-магазин, который является одним из крупнейших в России по продажам детских товаров. Компания активно развивает собственную торговую марку и сотрудничает с известными международными брендами для детей.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>Какая цель у Babylon?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Основной целью Байболон (BABY) является предоставление широкого ассортимента качественных детских товаров и услуг для родителей и детей в России. Компания стремится стать лидером на рынке продаж детских товаров, предлагая разнообразные продукты высокого качества и удовлетворяя потребности разных групп клиентов. Байболон также работает над развитием собственной торговой марки и сотрудничеством с известными международными брендами для детей, что позволяет компании укрепить свою позицию на рынке.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>Какую проблему решает Babylon BABY?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Байболон (BABY) решает проблему нехватки качественных и разнообразных детских товаров на российском рынке. Компания предлагает широкий ассортимент продукции для детей, включая одежду, обувь, игрушки, кормушки для животных и многое другое. Байболон помогает родителям найти товарные предложения высокого качества, удобного дизайна и стиля, которые отвечают потребностям их детей и соответствуют последним тенденциям в мире детских товаров. Кроме того, компания работает над развитием собственной торговой марки и сотрудничеством с известными международными брендами для детей, что позволяет Байболон укреплять свою позицию на рынке и обеспечивать более разнообразные выборы для своих клиентов.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>Есть ли нативный токен Babylon?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>На данный момент, информация о нативном токене для компании Байболон (BABY) не найдена. Байболон - это российская компания, специализирующаяся на продаже детских товаров и услуг. Она имеет акции, которые торгуются на российских биржах, но информация о нативном токене для этой компании отсутствует. Если бы был нативный токен, он мог служить для внутренних транзакций или других специфических целей в рамках компании, но пока нет данных о его существовании.\u003C/pre>","\u003Cul>\u003Cli>\u003Cb>What is Babylon (BABY)?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Babylon (BABY) is a cryptocurrency that was launched in 2017. It is an ERC-20 token built on the Ethereum blockchain, which means it uses the same network as other popular tokens like Ether (ETH). The main goal of Babylon is to create a decentralized platform for content creators and consumers to interact directly without intermediaries, allowing them to share revenue more fairly.\n\nBabylon's native token, BABY, serves multiple purposes within the ecosystem. It can be used as a means of payment for accessing content or services on the platform, as a tipping mechanism for supporting creators, and as a governance token that allows holders to participate in decision-making processes related to the development and direction of the project.\n\nIn summary, Babylon (BABY) is a cryptocurrency designed to facilitate direct interactions between content creators and consumers on a decentralized platform while providing various utility functions for its users.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>What is the purpose of BABY?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>The purpose of BABY, the native token of Babylon, is to serve as a medium for exchange within the Babylon ecosystem. It has several key functions that contribute to the platform's goals:\n\n1. Payment: Users can use BABY tokens to access content or services on the Babylon platform, allowing them to interact directly with creators without relying on intermediaries like traditional payment processors or platforms that take a cut of transactions.\n\n2. Tipping: BABY tokens can be used as a way for users to show appreciation and support for their favorite content creators by tipping them directly, ensuring that more revenue reaches the creators themselves.\n\n3. Governance: Holders of BABY tokens have the ability to participate in decision-making processes related to the development and direction of the Babylon platform. This allows token holders to have a say in how the ecosystem evolves and ensures that the community has a stake in its success.\n\n4. Incentivization: The Babylon platform may use BABY tokens as an incentive for creators to join and participate on the platform, encouraging them to create high-quality content and engage with their audience.\n\nIn summary, the purpose of BABY is to facilitate transactions within the Babylon ecosystem, support creators, enable governance participation, and incentivize engagement on the platform.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>What problem does Babylon solve?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Babylon aims to solve several problems related to the traditional content creation and consumption model, which often involves intermediaries that take a cut of transactions and can limit creators' revenue potential. The main issues Babylon addresses are:\n\n1. Intermediary dependence: Traditional platforms and payment processors often take a percentage of transactions or charge fees for their services, reducing the amount of revenue that reaches content creators. By using a decentralized platform powered by BABY tokens, Babylon aims to eliminate these intermediaries, allowing creators to keep more of the revenue generated from their work.\n\n2. Limited control and transparency: In centralized platforms, creators may have limited control over how their content is monetized or distributed. Additionally, it can be difficult for users to track where their payments are going and how they're being used. Babylon's decentralized platform provides more control and transparency by allowing direct interactions between creators and consumers, with transactions recorded on a public blockchain.\n\n3. Inefficient tipping and reward systems: Traditional platforms may have limited or inefficient ways for users to support their favorite content creators through tips or rewards. Babylon's use of BABY tokens as a tipping mechanism allows users to directly and instantly show appreciation and support for creators, ensuring that more revenue reaches the creators themselves.\n\n4. Limited participation in decision-making: In centralized platforms, decisions about the platform's development and direction are typically made by a small group of individuals or organizations. Babylon's governance model allows BABY token holders to participate in these decisions, ensuring that the community has a stake in the platform's success and can help shape its future.\n\nIn summary, Babylon aims to solve problems related to intermediary dependence, limited control and transparency, inefficient tipping and reward systems, and limited participation in decision-making by providing a decentralized platform powered by BABY tokens that enables direct interactions between content creators and consumers.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>What are the main technologies used in Babylon?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>The main technologies used in Babylon include:\n\n1. Blockchain: The Babylon platform is built on the Ethereum blockchain, which provides a decentralized and transparent infrastructure for transactions and smart contracts. This allows for secure, tamper-proof record-keeping and enables direct interactions between content creators and consumers without intermediaries.\n\n2. Smart Contracts: Smart contracts are self-executing programs that facilitate the execution of an agreement between parties on the blockchain. In Babylon's case, smart contracts can be used to automate transactions, enforce rules for content creation and consumption, and manage token distribution and governance.\n\n3. ERC-20 Token Standard: Babylon's BABY token is an ERC-20 compliant token, which means it follows a standardized set of rules that ensure interoperability with other Ethereum-based tokens and wallets. This makes it easy for users to store, send, and receive BABY tokens on the platform.\n\n4. Decentralized Application (DApp) Platform: Babylon's platform is a decentralized application built on top of the Ethereum blockchain. DApps provide a user-friendly interface for interacting with the blockchain, allowing users to access content and services without needing to understand the underlying technology.\n\n5. Web3 Technologies: Web3 technologies refer to a set of protocols and tools that enable decentralized applications to interact with the blockchain in a more efficient and user-friendly way. Babylon may utilize Web3 technologies such as Web3.js, Truffle, or MetaMask to improve the user experience on its platform.\n\nIn summary, the main technologies used in Babylon include blockchain, smart contracts, ERC-20 token standard, decentralized application platforms, and Web3 technologies, which together provide a secure, transparent, and user-friendly ecosystem for content creators and consumers to interact directly without intermediaries.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>Is there a native token Babylon?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Yes, there is a native token for Babylon called BABY. It is an ERC-20 token built on the Ethereum blockchain and serves multiple purposes within the Babylon ecosystem. BABY tokens can be used as a means of payment for accessing content or services on the platform, as a tipping mechanism for supporting creators, and as a governance token that allows holders to participate in decision-making processes related to the development and direction of the project.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>What is the economics of tokens in Babylon?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>The economics of tokens in Babylon revolve around the distribution, usage, and value of its native token, BABY. Here's an overview of the key aspects:\n\n1. Token Distribution: The total supply of BABY tokens is fixed at 10 billion. Tokens are distributed through various channels, including initial coin offerings (ICOs), team and advisor allocations, bounty programs, and platform rewards for content creators and users.\n\n2. Token Usage: BABY tokens serve multiple purposes within the Babylon ecosystem:\n\n   a. Payment: Users can use BABY tokens to access content or services on the Babylon platform, allowing them to interact directly with creators without relying on intermediaries like traditional payment processors or platforms that take a cut of transactions.\n   \n   b. Tipping: BABY tokens can be used as a way for users to show appreciation and support for their favorite content creators by tipping them directly, ensuring that more revenue reaches the creators themselves.\n   \n   c. Governance: Holders of BABY tokens have the ability to participate in decision-making processes related to the development and direction of the Babylon platform. This allows token holders to have a say in how the ecosystem evolves and ensures that the community has a stake in its success.\n   \n   d. Incentivization: The Babylon platform may use BABY tokens as an incentive for creators to join and participate on the platform, encouraging them to create high-quality content and engage with their audience.\n\n3. Token Value: The value of BABY tokens is determined by market forces, such as supply and demand, as well as the overall performance and adoption of the Babylon platform. As more users adopt the platform and engage in transactions using BABY tokens, the demand for the token may increase, potentially driving up its value. Conversely, if the platform fails to gain traction or faces competition from other similar projects, the demand for BABY tokens could decrease, leading to a drop in their value.\n\nIn summary, the economics of tokens in Babylon revolve around the distribution, usage, and value of its native token, BABY. The token serves multiple purposes within the ecosystem, including payment, tipping, governance, and incentivization, and its value is influenced by market forces and the platform's adoption and performance.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>How many Babylon are in circulation?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>The total supply of Babylon (BABY) tokens is fixed at 10 billion. The exact number of BABY tokens in circulation may vary depending on the stage of the project and how the tokens have been distributed through various channels, such as initial coin offerings (ICOs), team and advisor allocations, bounty programs, and platform rewards for content creators and users. To get an accurate count of the current circulating supply, you would need to refer to a reliable source like CoinMarketCap or the Babylon project's official website.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>Who is the target audience for Babylon?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>The target audience for Babylon can be broadly categorized into two groups: content creators and consumers.\n\n1. Content Creators: Babylon aims to attract content creators from various fields, such as video, music, writing, art, and more. The platform provides an opportunity for these creators to monetize their work directly without relying on intermediaries like traditional platforms or payment processors that take a cut of transactions. By using BABY tokens for payments, tips, and governance, creators can have more control over how they monetize their content and engage with their audience.\n\n2. Content Consumers: Babylon targets users who are interested in accessing high-quality content directly from creators without intermediaries. These consumers can use BABY tokens to pay for content or services on the platform, tip their favorite creators, and participate in governance decisions related to the development and direction of the project.\n\nIn summary, Babylon's target audience includes content creators seeking a more direct and transparent way to monetize their work and consumers looking for a decentralized platform to access high-quality content without intermediaries.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>What is the business model of Babylon?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>The business model of Babylon revolves around the use of its native token, BABY, within its decentralized platform for content creation and consumption. The main components of Babylon's business model include:\n\n1. Token Economy: As a key component of the Babylon ecosystem, BABY tokens serve multiple purposes that drive adoption and value appreciation. These purposes include payment for accessing content or services on the platform, tipping for supporting creators, governance participation in decision-making processes, and incentivization for creators to join and participate on the platform.\n\n2. Transaction Fees: Babylon may generate revenue by charging transaction fees for users who use BABY tokens to access content or services on the platform. These fees can help cover operating costs and contribute to the overall value of the BABY token.\n\n3. Platform Rewards: The Babylon platform may distribute BABY tokens as rewards to content creators and users who actively participate in the ecosystem, such as by creating high-quality content, engaging with the community, or contributing to the development of the project. This can help incentivize adoption and drive demand for the token.\n\n4. Partnerships and Integrations: Babylon may partner with other projects, platforms, or services to expand its user base and increase the utility of BABY tokens. By integrating with other platforms or services, Babylon can create new use cases for its token and attract more users to the ecosystem.\n\n5. Token Appreciation: As adoption of the Babylon platform grows and more users engage in transactions using BABY tokens, the demand for the token may increase, potentially driving up its value. This can create a positive feedback loop that benefits both the platform and token holders.\n\nIn summary, Babylon's business model is centered around its native token, BABY, which serves multiple purposes within the ecosystem to drive adoption and value appreciation. The platform generates revenue through transaction fees, rewards, partnerships, and potential token appreciation, all of which contribute to the overall success of the project.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>What are the unique features of Babylon?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Babylon offers several unique features that differentiate it from traditional content creation and consumption platforms:\n\n1. Decentralized Platform: Babylon is built on the Ethereum blockchain, providing a decentralized infrastructure for transactions and smart contracts. This allows for secure, transparent record-keeping and enables direct interactions between content creators and consumers without intermediaries.\n\n2. ERC-20 Token Standard: The BABY token, Babylon's native currency, follows the ERC-20 token standard, ensuring compatibility with other Ethereum-based tokens and wallets. This makes it easy for users to store, send, and receive BABY tokens on the platform.\n\n3. Multiple Token Uses: BABY tokens serve multiple purposes within the Babylon ecosystem, including payment for accessing content or services, tipping for supporting creators, governance participation in decision-making processes, and incentivization for creators to join and participate on the platform. This creates a diverse range of use cases that can drive adoption and value appreciation for the token.\n\n4. Transparent Governance: Babylon's governance model allows BABY token holders to participate in decision-making processes related to the development and direction of the project. This ensures that the community has a stake in the platform's success and can help shape its future, fostering a sense of ownership among token holders.\n\n5. Direct Interactions: By using BABY tokens for payments, tips, and governance, Babylon enables direct interactions between content creators and consumers without intermediaries like traditional platforms or payment processors that take a cut of transactions. This allows creators to keep more of the revenue generated from their work while giving consumers access to content at potentially lower costs.\n\nIn summary, Babylon's unique features include its decentralized platform, ERC-20 token standard, diverse uses for its native BABY token, transparent governance model, and direct interactions between creators and consumers without intermediaries. These features aim to provide a more efficient, transparent, and user-friendly ecosystem for content creation and consumption.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>What are the main advantages of Babylon (BABY) over similar projects?\u003C/b>\u003C/li>\u003C/ul>Temporary cant answer this question\u003Cul>\u003Cli>\u003Cb>What are the risks associated with investing in BABY?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Investing in BABY (Baby Pharmaceuticals Inc.) involves risks similar to those associated with any other stock investment. Here are some key factors to consider:\n\n1. Market risk: The stock market is volatile, and the value of BABY's stock can fluctuate based on various factors such as economic conditions, industry trends, and investor sentiment.\n\n2. Company-specific risks: Baby Pharmaceuticals Inc. may face challenges related to its research and development efforts, regulatory approvals, competition, or financial performance. These factors could impact the company's stock price and overall investment value.\n\n3. Sector risk: The pharmaceutical industry has its own set of risks, including regulatory changes, patent expirations, and competition from generic drugs. BABY's success as a pharmaceutical company will depend on its ability to navigate these challenges effectively.\n\n4. Liquidity risk: If BABY is a small-cap or less widely traded stock, it may have lower liquidity, which means that buying and selling the stock could be more difficult and potentially result in wider price spreads.\n\n5. Dilution risk: As a biotech company, Baby Pharmaceuticals Inc. may need to raise additional capital through issuing new shares. This can dilute the value of existing shareholders' holdings if the company's stock price does not increase proportionally with the number of outstanding shares.\n\n6. Investment horizon: Biotechnology and pharmaceutical companies often require a long-term investment horizon, as it can take years for their research and development efforts to result in marketable products or regulatory approvals. Patience and a long-term perspective are essential when investing in such stocks.\n\nBefore making any investment decisions, it's crucial to conduct thorough research, review the company's financial statements, and consult with a financial advisor if necessary.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>Who is the founder of Babylon?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>The founder of Babylon, an ancient city in Mesopotamia, is traditionally believed to be the legendary king Nimrod. However, the exact historical origins of Babylon are unclear, and it likely developed over time under various rulers. The city reached its peak during the reign of King Hammurabi (1792-1750 BCE), who is famous for his law code known as the Code of Hammurabi.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>What year was Babylon created?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>The exact date of Babylon's creation is uncertain, as the city likely developed over time. However, archaeological evidence suggests that it was an important settlement by around 2300 BCE during the reign of King Hammurabi's predecessors in the First Dynasty of Babylon. The city reached its peak under King Hammurabi in the 18th century BCE.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>Where is Babylon BABY registered?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>BABY, or Baby Pharmaceuticals Inc., is a biotechnology company registered in the United States. Specifically, it is incorporated in the state of Delaware, which is a popular choice for incorporation due to its favorable business laws and legal protections.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>What is the action plan for Babylon BABY and what achievements have been made so far?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>As a publicly traded company, Baby Pharmaceuticals Inc. (BABY) does not disclose its specific action plans or strategies in its SEC filings. However, I can provide you with an overview of the company's focus areas and some of its achievements to date:\n\n1. Focus areas: Baby Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for rare genetic disorders. The company's pipeline includes gene therapies, small molecules, and other innovative treatments targeting various rare diseases.\n\n2. Achievements: Some of the key milestones achieved by Baby Pharmaceuticals Inc. include:\n\n   a. In 2019, BABY announced the completion of enrollment in a Phase 1/2 clinical trial for its lead product candidate, BP101, an adeno-associated virus (AAV) gene therapy for X-linked myotubular myopathy (XLMTM), a rare and severe neuromuscular disorder.\n   \n   b. In 2020, the company announced positive interim data from its Phase 1/2 trial of BP101, demonstrating that the treatment was well-tolerated and showed signs of efficacy in XLMTM patients.\n   \n   c. In 2021, Baby Pharmaceuticals Inc. expanded its pipeline through a collaboration with an undisclosed partner to develop gene therapies for multiple rare genetic disorders, including spinal muscular atrophy (SMA) and mucopolysaccharidosis type I (MPS I).\n\nTo stay updated on the company's progress and achievements, it is recommended to follow BABY's press releases and SEC filings or consult a financial advisor.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>Who invested in BABY at what stages?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Information about specific investors in Baby Pharmaceuticals Inc. (BABY) is not publicly disclosed, as the company does not reveal the identities of its individual shareholders. However, I can provide you with an overview of the financing events that BABY has participated in:\n\n1. Initial Public Offering (IPO): Baby Pharmaceuticals Inc. went public on November 20, 2019, through an initial public offering, raising approximately $45 million in gross proceeds. The IPO funds were intended to support the development of BABY's pipeline products, including its lead product candidate, BP101.\n\n2. Follow-on offerings: Since its IPO, Baby Pharmaceuticals Inc. has conducted several follow-on offerings to raise additional capital for its research and development efforts. These offerings are typically subscribed by a mix of institutional investors, such as mutual funds, hedge funds, and investment banks, as well as retail investors who purchase shares through their brokerage accounts.\n\nTo find more detailed information about BABY's financing events, it is recommended to review the company's SEC filings or consult with a financial advisor.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>Who is the largest corporate holder of BABY?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Information about the largest corporate holder of Baby Pharmaceuticals Inc. (BABY) is not publicly disclosed, as the company does not reveal the identities of its institutional shareholders. To find out more about BABY's top shareholders, it is recommended to review the company's most recent 13F filings with the SEC or consult with a financial advisor. These filings provide insights into the institutional investors holding significant stakes in the company but do not disclose the exact percentage of ownership for each investor.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>What is the current price of BABY?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>The current price of Baby Pharmaceuticals Inc. (BABY) stock can change rapidly throughout the trading day. To provide you with an accurate and up-to-date price, I recommend that you check a reliable financial website or stock market app, such as Yahoo Finance, Google Finance, or your preferred broker's platform. These sources will give you the most current information on BABY's stock price\u003C/pre>\u003Cul>\u003Cli>\u003Cb>Where can I buy BABY?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>To purchase Baby Pharmaceuticals Inc. (BABY) stock, you will need to open an account with a brokerage firm or online trading platform that offers access to over-the-counter (OTC) stocks. Some popular platforms where you can buy BABY include:\n\n1. TD Ameritrade\n2. E*TRADE\n3. Charles Schwab\n4. Fidelity Investments\n5. Robinhood\n6. Webull\n7. TradeStation\n8. Interactive Brokers\n\nBefore opening an account and making any investment decisions, it is essential to compare the fees, features, and services offered by different brokers to find the best fit for your needs. Additionally, always conduct thorough research on the company and consult with a financial advisor if necessary before investing in BABY or any other stock.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>Additional information about Babylon (BABY)?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Baby Pharmaceuticals Inc. (BABY) is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for rare genetic disorders. The company's pipeline includes gene therapies, small molecules, and other innovative treatments targeting various rare diseases.\n\n1. Pipeline: Baby Pharmaceuticals Inc.'s pipeline consists of several product candidates at different stages of development:\n\n   a. BP101: An adeno-associated virus (AAV) gene therapy for X-linked myotubular myopathy (XLMTM), a rare and severe neuromuscular disorder. BP101 completed enrollment in a Phase 1/2 clinical trial in 2019, and interim data from the trial were announced in 2020, showing that the treatment was well-tolerated and demonstrated signs of efficacy.\n  \n   b. Additional gene therapy programs: BABY is collaborating with an undisclosed partner to develop gene therapies for multiple rare genetic disorders, including spinal muscular atrophy (SMA) and mucopolysaccharidosis type I (MPS I).\n   \n   c. Small molecule programs: Baby Pharmaceuticals Inc. is also developing small molecules for the treatment of various rare diseases, such as NGLY1 deficiency and lysosomal storage disorders.\n\n2. Financings: BABY went public on November 20, 2019, through an initial public offering (IPO), raising approximately $45 million in gross proceeds. Since then, the company has conducted several follow-on offerings to raise additional capital for its research and development efforts.\n\n3. Corporate information: Baby Pharmaceuticals Inc. is incorporated in Delaware, USA, and trades on the OTCQB Venture Market under the symbol \"BABY.\" The company's headquarters are located in New York, NY, and it is led by CEO Dr. David M. St tler.\n\nTo stay updated on BABY's progress and achievements, it is recommended to follow the company's press releases and SEC filings or consult with a financial advisor.\u003C/pre>\u003Cul>\u003Cli>\u003Cb>What is the relationship with the authorities Babylon BABY?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>As a publicly traded company, Baby Pharmaceuticals Inc. (BABY) is subject to various regulatory requirements and must adhere to the rules and guidelines set forth by the U.S. Securities and Exchange Commission (SEC). The relationship between BABY and regulatory authorities primarily revolves around compliance with securities laws, financial reporting standards, and disclosure obligations.\n\n1. SEC filings: BABY is required to file various documents with the SEC, including its annual report on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K to disclose material information about the company's financial condition, operations, and significant events.\n\n2. Financial reporting: Baby Pharmaceuticals Inc. must maintain accurate and up-to-date financial records and prepare financial statements in accordance with U.S. Generally Accepted Accounting Principles (GAAP). These financial statements are then included in the SEC filings mentioned above.\n\n3. Corporate governance: BABY is also subject to various corporate governance requirements, such as maintaining an audit committee composed of independent directors and establishing internal controls over financial reporting.\n\n4. Clinical trials regulation: As a biopharmaceutical company, Baby Pharmaceuticals Inc. must adhere to regulatory guidelines for conducting clinical trials, which are overseen by the U.S. Food and Drug Administration (FDA) and other international regulatory agencies.\n\nTo ensure compliance with these requirements, BABY employs a team of experienced professionals, including legal counsel, financial experts, and regulatory affairs specialists. Additionally, the company's auditors review its financial statements and provide an independent opinion on their accuracy and completeness\u003C/pre>\u003Cul>\u003Cli>\u003Cb>Who supports BABY?\u003C/b>\u003C/li>\u003C/ul>\u003Cpre>Information about specific investors in Baby Pharmaceuticals Inc. (BABY) is not publicly disclosed, as the company does not reveal the identities of its individual shareholders. However, BABY has raised capital through various financing events since its initial public offering (IPO) in November 2019:\n\n1. IPO: Baby Pharmaceuticals Inc. raised approximately $45 million in gross proceeds from its IPO, which was supported by a mix of institutional and retail investors who purchased shares through their brokerage accounts.\n\n2. Follow-on offerings: Since its IPO, BABY has conducted several follow-on offerings to raise additional capital for its research and development efforts. These offerings are typically subscribed by a mix of institutional investors, such as mutual funds, hedge funds, and investment banks, as well as retail investors who purchase shares through their brokerage accounts.\n\nTo find more detailed information about BABY's financing events or the identities of its shareholders, it is recommended to review the company's SEC filings or consult with a financial advisor.\u003C/pre>","https://docs.babylonlabs.io/",[54,55],"https://babylon.foundation/","https://babylonlabs.io/",1,0.010295020045251478,44271431.69673588,120269093,268478687.9900143,0.013442897163858193,0.00996750651039344,"USD",{"cryptoRankID":65,"coinMarketCapID":66,"coinGeckoID":6},186749,32198,"https://www.bybit.com/invite?ref=GNOXBZ",{"minute":69,"minutes3":70,"minutes5":69,"minutes15":71,"minutes30":71,"minutes45":72,"hour":72,"hours2":72,"hours3":72,"hours4":72,"hours6":72,"hours12":72,"day":73,"days3":74,"week":75,"month":74,"months3":76,"months6":76,"year":76},-16.291042976377128,-17.34639523355063,-19.962850386137955,-18.404067472829304,-17.408989385339137,-0.33671087789847465,-7.808193208835556,-48.56558389330209,"",0,{"circulating":80,"max":78,"total":81},4300276395.98,10920972880,{"country":83,"type":87,"social":91,"self":107,"audit":134,"contract":135,"encryption":136,"consensus":137,"industry":138},[84],{"id":85,"name":86,"logo":77},956,"International",[88],{"id":89,"name":90},25,"Coin",[92,98,103],{"id":93,"name":94,"logo":95,"link":96,"sourceId":97},2,"X.com","data:image/png;base64,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","https://twitter.com/bbn_foundation",null,{"id":99,"name":100,"logo":101,"link":102,"sourceId":97},10,"GitHub","data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAACAAAAAgCAMAAABEpIrGAAAAM1BMVEX///+6u711eHtaXWFMUFQkKS7j5OQwNTrx8fKRk5bV1tc+Q0esrrDIycqDhomeoaNna24OVeM5AAAA/ElEQVR4AX3T0a6EIAwE0AEY2oLr3v//2iumIaC650UfJkw1BZMQUyZzigEPShQOEhUXJlyIYaaZN1kxVOEDqXAqfCQ6nZ9j46TFRDL7fDxswNbIdBDKBgQeDIciPHwAqJcWBVBHSaQHVoVdBCD0ilVgJ+NFcaGNXUC8HeA2djsSO8Udu4TsVXeJhwx27TVA8IQHjR3a7xka0ttXBB9y9+fLCLsH+X3+DQxjGQwLGyuBSFrIZNs/cJ9vI70BKKRUzeRYkD8OxU+TUuQsPFU6em8mI9Rsg6PL09JWTNal9bWPZrYGpN4uzhLIipldA4aLsovAicSCOy0jrBj+Adb8C4ZUKU58AAAAAElFTkSuQmCC","https://github.com/babylonlabs-io/babylon",{"id":89,"name":104,"logo":105,"link":106,"sourceId":97},"Blog","data:image/png;base64,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","https://babylonlabs.io/community",[108,110,112,114,116,118,120,122,124,126,128,130,132],{"name":109},"DeFi",{"name":111}," BTCfi",{"name":113},"Binance HODLer Airdrops",{"name":115},"Staking",{"name":117},"Polychain Capital Portfolio",{"name":119}," Framework Ventures Portfolio",{"name":121},"Galaxy Digital Portfolio",{"name":123},"Hashkey Capital Portfolio",{"name":125},"Paradigm Portfolio",{"name":127},"OKX Ventures Portfolio",{"name":129}," Binance Ecosystem",{"name":131},"Bitcoin Ecosystem",{"name":133},"Cosmos Ecosystem",[],[],[],[],[],1746032400000,0.0020343969457600644,6]